The device, WilloMD, functions as “a GPS for joint pain,” the company said in a release. It aims to address toxic joint system by giving patients an immune system boost to help repair and heal toxicity and inflammation brought on by injury. With age and increased damage, this repair process slows and toxicity can accumulate, damaging cartilage, soft tissue and meniscus, the release said.
Related Articles on Pain Management:
Study Finds Link Between Opioid Use, Hypogonadism
Lyrica No More Effective Than Placebo Painkillers
Patients With Celiac Disease More Likely to Suffer Migraines
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
